Tumor oxygenation correlates with molecular growth determinants in breast cancer

Breast Cancer Research and Treatment

Volumn 48, Issue 2, 1998, Pages 97-106

  Hohenberger, Peter ^a,b   Felgner, Conrad ^a   Haensch, Wolfgang ^a   Schlag, Peter M ^a  

^a Section of Pathology   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Breast cancer; Molecular markers; Oxygen partial pressure; Prognostic factors

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; HEMOGLOBIN; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P53; PROTEIN PS2;

ADULT; AGED; ANTIGEN EXPRESSION; ARTERIAL GAS; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER SURGERY; CELL PROLIFERATION; CLINICAL ARTICLE; ECHOGRAPHY; FEMALE; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; MALE; ONCOGENE C ERB; OXYGEN CONSUMPTION; OXYGEN TENSION; OXYGENATION; POLAROGRAPHY; PRIORITY JOURNAL; PROGNOSIS; TEMPERATURE; TUMOR VOLUME;

EID: 0031970946     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005921513083     Document Type: Article

References (43)

1. Vaupel P, Kallinowski F, Okunieff P: Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49: 6449-6465, 1989
2. Gatenby RA, Kessler HB, Rosenblum JS, Coia LR, Moldofsky PJ, Hartz WH, Broder GJ: Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 14: 831-838, 1988
3. Okunieff P, Hoeckel M, Dunphy EP, Schlenger K, Knoop C, Vaupel P: Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone. Int J Radiat Oncol Biol Phys 26: 631-636, 1993
4. Wike-Hooley JL, Haveman J, Reinhold HS: The relevance of tumor pH to the treatment of malignant disease. Radiother Oncol 2: 343-366, 1984
5. Young SD, Hill RP: Effects of reoxygenation on cells from hypoxic regions of solid tumors: anticancer drug sensitivity and metastatic potential. J Natl Cancer Inst 82: 371-380, 1990
6. Brizel DM, Scully SP, Harrelson J, Layfield LJ, Bean J, Prosnitz LR, Dewhirst MW: Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56: 941-943, 1996
7. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 26: 45-50, 1993
8. Vaupel P, Fortmeyer HP, Runkel S, Kallinowski F: Blood flow, oxygen consumption, and tissue oxygenation of human breast cancer xenografts in nude rats. Cancer Res 47: 3496-3503, 1987
9. Teicher BA, Sotomayor EA, Dupuis NP, Kusumoto T, Menon K: Reduced oxygenation in a rat mammary carcinoma after chemo-or radiation therapy and reoxygenation with perflubron emulsion/carbogen breathing. J Cancer Res Clin Oncol 120: 593-598, 1994
10. Vaupel P, Schlenger KH, Hoeckel M, Okunieff P: Oxygenation of mammary tumors: from isotransplanted rodent tumors to primary malignancies in patients. Adv Exp Med Biol 316: 361-371, 1992
11. 2-histography. Adv Exp Med Biol 345: 451-458, 1994
12. Vaupel P, Schlenger K, Knoop C, Hockel M: Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res 51: 3316-3322, 1991
13. Foekens JA, van Putten WL, Portengen H, de Koning HY, Thirion B, Alexieva Figuseh J, Klijn JG: Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis. J Clin Oncol II: 899-908, 1993
14. Foekens JA, Portengen H, Look MP, van Putten WL, Thirion B, Bontenbal M, Klijn JG: Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer. Br J Cancer 70: 1217-1223, 1994
15. Fitzpatrick SL, Brightwell J, Wittliff JL, Barrows GH, Schultz GS: Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels. Cancer Res 44: 3448-3453, 1984
16. Klijn JG, Look MP, Portengen H, Alexieva Figusch J, van Putten WL, Foekens JA: The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: results of a 10 year follow-up study. Breast Cancer Res Treat 29: 73-83, 1994
17. Toi M, Tominaga T, Osaki A, Toge T: Role of epidermal growth factor receptor expression in primary breast cancer: results of a biochemical study and an immunocytochemical study. Breast Cancer Res Treat 29: 51-58, 1994
18. Nicholson RI, McClelland RA, Finlay P, Eaton CL, Gullick WJ, Dixon AR, Robertson JF, Ellis IO, Blamey RW: Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity. Eur J Cancer 29A: 1018-1023, 1993
19. Shrestha P, Yamada K, Wada T, Maeda S, Watatani M, Yasutomi M, Takagi H, Mori M: Proliferating cell nuclear antigen in breast lesions: correlation of c-erbB-2 oncoprotein and EGF receptor and its clinicopathological significance in breast cancer. Virchows Arch Path Anal A 421: 193-202, 1992
20. Ji H, Lipponen P, Aaltomaa S, Syrjanen K, Syrjanen S: c-erb-B2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer. Anticancer Res 13:1147-1152, 1993
21. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ulrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182, 1987
22. Seshadri R, Firgaira FA, Horsfall DJ, McCaul K, Setlur V, Kitchen P: Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group. J Clin Oncol 11: 1936-1942, 1993
23. Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW, Chamness GC, Osborne CK, McGuire WL: Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 85: 200-206, 1993
24. Westley BR, May FE: Cathepsin D and breast cancer. Eur J Cancer 32A: 15-24, 1996
25. Briozzo P, Morisset M, Capony F, Rougeot C, Rochefort H: In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res 48: 3688-3692, 1988
26. Thor AD, Moore DH II, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen LC, Mayall BH et al.: Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 84: 845-855, 1992
27. Marks JR, Humphrey PA, Wu K, Berry D, Bandarenko N, Kerns BJ, Iglehart JD: Overexpression of p53 and HER-2/ neu proteins as prognostic markers in early stage breast cancer. Ann Surg 219: 332-341, 1994
28. Salven P, Joensuu H, Heikkila P, Matikainen MT, Wasenius VM, Alanko A, Alitalo K: Endothelial Tie growth factor receptor provides antigenic marker for assessment of breast cancer angiogenesis. Br J Cancer 74: 69-72, 1996
29. Bevilacqua P, Barbareschi M, Verderio P, Boracchi P, Caffo O, Dalla Palma P, Meli S, Weidner N, Gasparini G: Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma - results of a multiparametric study. Breast Cancer Res Treat 36: 205-217, 1995
30. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KA, Stein H, Mason DY: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP complexes). J Histochem Cytochem 32: 219-229, 1984
31. Thews O, Vaupel P: Relevant parameters for describing the oxygenation status of solid tumors. Strahlenther Onkol 172: 239-243, 1996
32. Boucher Y, Baxter LT, Jain RK: Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res 50: 4478-4484, 1990
33. Roh HD, Boucher Y, Kalnicki S, Buchsbaum R, Bloomer WD, Jain RK: Interstitial hypertension in carcinoma of uterine cervix in patients: possible correlation with tumor oxygenation and radiation response. Cancer Res 51: 6695-6698, 1991
34. Wiedemann G, Roszinski S, Biersack A, Weiss C, Wagner T: Local hyperthermia enhances cyclophosphamide, ifosfamide and cis-diamminedichloroplatinum cytotoxicity on human-derived breast carcinoma and sarcoma xenografts in nude mice. J Cancer Res Clin Oncol 118: 129-135, 1992
35. Hohenberger P, Finke LH, Schlag PM: Intracompartmental pressure during hyperthermic isolated limb perfusion for melanoma and sarcoma. Eur J Surg Oncol 22: 147-151, 1996
36. Rochefort H: The prognostic value of cathepsin D in breast cancer. A long road to the clinic. Eur J Cancer 32A: 7-8, 1996
37. Kalra J, Prasad K: Oxygen free radicals and cardiac depression. Clin Biochem 27: 163-168, 1994
38. Monschke F, Muller WU, Winkler U, Streffer C: Cell proliferation and vascularization in human breast carcinomas. Int J Cancer 48: 812-815, 1991
39. Zeman EM, Calkins DP, Cline JM, Thrall DE, Raleigh JA: The relationship between proliferative and oxygenation status in spontaneous canine tumors. Int J Radiat Oncol Biol Phys 27: 891-898, 1993
40. Elledge RM, Allred DC: The p53 tumor suppressor gene in breast cancer. Breast Cancer Res Treat 32: 39-47, 1994
41. Palacios J, Benito N, Pizarro A, Limeres MA, Suarez A, Cano A, Gamallo C: Relationship between ERBB2 and E-cadherin expression in human breast cancer. Virchows Arch 427: 259-263, 1995
42. Wiltschke C, Kindas Muegge I, Steininger A, Reiner A, Reiner G, Preis PN: Coexpression of HER-2/neu and p53 is associated with a shorter disease-free survival in node-positive breast cancer patients. J Cancer Res Clin Oncol 120: 737-742, 1994
43. Horiguchi J, Iino Y, Takei H: Expression of pS2 estrogen-inducible protein in primary breast cancer. Oncology 53: 12-15, 1996